CD40 signaling in graves disease is mediated through canonical and noncanonical thyroidal nuclear factor kB activation

Hanna J. Lee, Angela Lombardi, Mihaela Stefan, Cheuk Wun Li, William B. Inabnet, Randall P. Owen, Erlinda Concepcion, Yaron Tomer

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

CD40, a tumor necrosis factor receptor, is a major immune-modulating susceptibility gene for Graves disease (GD) as well as for a variety of other autoimmune diseases. Its broad association with autoimmunity underscores its paramount role in the development of a normal adaptive immune response, primarily in coordinating effective antigen presentation. The molecular pathways by which CD40 activation in the thyroid induces GD are unknown. In this study, we investigated whether NF-κB, a ubiquitious family of transcription factors, mediates the downstream effects of thyroid-specific CD40 activation. Cultured primary human thyrocytes, from patients with and without GD, underwent CD40 stimulation. Once stimulated, cytokines and transcription factors specific for either the canonical nuclear factor κB (NF-κB)1 pathway [interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-α], which primarily recruits cells for innate immunity, or the noncanonical NF-κB2 pathway [B cell-activating factor of the TNF family, CC chemokine ligand (CCL)21], which directs B cell viability, were analyzed. Significant upregulation in the messenger RNA and protein levels of both canonical and noncanonical pathway cytokines was observed. Western blot analyses of the specific transcription factors for the NF-κB1 and NF-κB2 pathways (p65 and p100/p52, respectively) demonstrated that p65 is constitutively expressed. In contrast, CD40 stimulation robustly increased the expression of the NF-κB2 p52 transcription factor, and the upregulation was significantly more profound in the GD tissue than in the normal thyroid tissue. Our data show that CD40 activity in thyrocytes is prominently mediated via NF-κB and furthermore suggest that the NF-κB1 and NF-κB2 pathways both contribute to the triggering and the progression of GD.

Original languageEnglish (US)
Pages (from-to)410-418
Number of pages9
JournalEndocrinology
Volume158
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

Graves Disease
Thyroid Gland
Transcription Factors
Up-Regulation
Tumor Necrosis Factor-alpha
B-Cell Activating Factor
NFI Transcription Factors
Cytokines
CC Chemokines
Tumor Necrosis Factor Receptors
Antigen Presentation
Adaptive Immunity
Autoimmunity
Interleukin-8
Innate Immunity
Autoimmune Diseases
Interleukin-6
Cell Survival
B-Lymphocytes
Western Blotting

ASJC Scopus subject areas

  • Endocrinology

Cite this

CD40 signaling in graves disease is mediated through canonical and noncanonical thyroidal nuclear factor kB activation. / Lee, Hanna J.; Lombardi, Angela; Stefan, Mihaela; Li, Cheuk Wun; Inabnet, William B.; Owen, Randall P.; Concepcion, Erlinda; Tomer, Yaron.

In: Endocrinology, Vol. 158, No. 2, 01.02.2017, p. 410-418.

Research output: Contribution to journalArticle

@article{a3e49ad15f264046a906f1e4d24ff26d,
title = "CD40 signaling in graves disease is mediated through canonical and noncanonical thyroidal nuclear factor kB activation",
abstract = "CD40, a tumor necrosis factor receptor, is a major immune-modulating susceptibility gene for Graves disease (GD) as well as for a variety of other autoimmune diseases. Its broad association with autoimmunity underscores its paramount role in the development of a normal adaptive immune response, primarily in coordinating effective antigen presentation. The molecular pathways by which CD40 activation in the thyroid induces GD are unknown. In this study, we investigated whether NF-κB, a ubiquitious family of transcription factors, mediates the downstream effects of thyroid-specific CD40 activation. Cultured primary human thyrocytes, from patients with and without GD, underwent CD40 stimulation. Once stimulated, cytokines and transcription factors specific for either the canonical nuclear factor κB (NF-κB)1 pathway [interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-α], which primarily recruits cells for innate immunity, or the noncanonical NF-κB2 pathway [B cell-activating factor of the TNF family, CC chemokine ligand (CCL)21], which directs B cell viability, were analyzed. Significant upregulation in the messenger RNA and protein levels of both canonical and noncanonical pathway cytokines was observed. Western blot analyses of the specific transcription factors for the NF-κB1 and NF-κB2 pathways (p65 and p100/p52, respectively) demonstrated that p65 is constitutively expressed. In contrast, CD40 stimulation robustly increased the expression of the NF-κB2 p52 transcription factor, and the upregulation was significantly more profound in the GD tissue than in the normal thyroid tissue. Our data show that CD40 activity in thyrocytes is prominently mediated via NF-κB and furthermore suggest that the NF-κB1 and NF-κB2 pathways both contribute to the triggering and the progression of GD.",
author = "Lee, {Hanna J.} and Angela Lombardi and Mihaela Stefan and Li, {Cheuk Wun} and Inabnet, {William B.} and Owen, {Randall P.} and Erlinda Concepcion and Yaron Tomer",
year = "2017",
month = "2",
day = "1",
doi = "10.1210/en.2016-1609",
language = "English (US)",
volume = "158",
pages = "410--418",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - CD40 signaling in graves disease is mediated through canonical and noncanonical thyroidal nuclear factor kB activation

AU - Lee, Hanna J.

AU - Lombardi, Angela

AU - Stefan, Mihaela

AU - Li, Cheuk Wun

AU - Inabnet, William B.

AU - Owen, Randall P.

AU - Concepcion, Erlinda

AU - Tomer, Yaron

PY - 2017/2/1

Y1 - 2017/2/1

N2 - CD40, a tumor necrosis factor receptor, is a major immune-modulating susceptibility gene for Graves disease (GD) as well as for a variety of other autoimmune diseases. Its broad association with autoimmunity underscores its paramount role in the development of a normal adaptive immune response, primarily in coordinating effective antigen presentation. The molecular pathways by which CD40 activation in the thyroid induces GD are unknown. In this study, we investigated whether NF-κB, a ubiquitious family of transcription factors, mediates the downstream effects of thyroid-specific CD40 activation. Cultured primary human thyrocytes, from patients with and without GD, underwent CD40 stimulation. Once stimulated, cytokines and transcription factors specific for either the canonical nuclear factor κB (NF-κB)1 pathway [interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-α], which primarily recruits cells for innate immunity, or the noncanonical NF-κB2 pathway [B cell-activating factor of the TNF family, CC chemokine ligand (CCL)21], which directs B cell viability, were analyzed. Significant upregulation in the messenger RNA and protein levels of both canonical and noncanonical pathway cytokines was observed. Western blot analyses of the specific transcription factors for the NF-κB1 and NF-κB2 pathways (p65 and p100/p52, respectively) demonstrated that p65 is constitutively expressed. In contrast, CD40 stimulation robustly increased the expression of the NF-κB2 p52 transcription factor, and the upregulation was significantly more profound in the GD tissue than in the normal thyroid tissue. Our data show that CD40 activity in thyrocytes is prominently mediated via NF-κB and furthermore suggest that the NF-κB1 and NF-κB2 pathways both contribute to the triggering and the progression of GD.

AB - CD40, a tumor necrosis factor receptor, is a major immune-modulating susceptibility gene for Graves disease (GD) as well as for a variety of other autoimmune diseases. Its broad association with autoimmunity underscores its paramount role in the development of a normal adaptive immune response, primarily in coordinating effective antigen presentation. The molecular pathways by which CD40 activation in the thyroid induces GD are unknown. In this study, we investigated whether NF-κB, a ubiquitious family of transcription factors, mediates the downstream effects of thyroid-specific CD40 activation. Cultured primary human thyrocytes, from patients with and without GD, underwent CD40 stimulation. Once stimulated, cytokines and transcription factors specific for either the canonical nuclear factor κB (NF-κB)1 pathway [interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-α], which primarily recruits cells for innate immunity, or the noncanonical NF-κB2 pathway [B cell-activating factor of the TNF family, CC chemokine ligand (CCL)21], which directs B cell viability, were analyzed. Significant upregulation in the messenger RNA and protein levels of both canonical and noncanonical pathway cytokines was observed. Western blot analyses of the specific transcription factors for the NF-κB1 and NF-κB2 pathways (p65 and p100/p52, respectively) demonstrated that p65 is constitutively expressed. In contrast, CD40 stimulation robustly increased the expression of the NF-κB2 p52 transcription factor, and the upregulation was significantly more profound in the GD tissue than in the normal thyroid tissue. Our data show that CD40 activity in thyrocytes is prominently mediated via NF-κB and furthermore suggest that the NF-κB1 and NF-κB2 pathways both contribute to the triggering and the progression of GD.

UR - http://www.scopus.com/inward/record.url?scp=85011665709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011665709&partnerID=8YFLogxK

U2 - 10.1210/en.2016-1609

DO - 10.1210/en.2016-1609

M3 - Article

VL - 158

SP - 410

EP - 418

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 2

ER -